SCHEMBL4265890

SCHEMBL4265890

CC(C)(C)OC(=O)N1CCNCC1S(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 4/20 0.41
▸ PRKD3 O94806 2/20 0.38
▸ PRKCG P05129 2/20 0.38
▸ PRKCB P05771 2/20 0.38
▸ PRKCA P17252 2/20 0.38
▸ PRKACA P17612 2/20 0.38
▸ PRKACG P22612 2/20 0.38
▸ PRKACB P22694 2/20 0.38
▸ PRKCH P24723 2/20 0.38
▸ PRKCI P41743 2/20 0.38
▸ PRKCE Q02156 2/20 0.38
▸ PRKCQ Q04759 2/20 0.38
▸ PRKCZ Q05513 2/20 0.38
▸ PRKCD Q05655 2/20 0.38
▸ PRKD1 Q15139 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2253695 0.83 NR1H2 (0.44) MAPK1NR1H2NR1H3PARP1
SCHEMBL30080495 0.81 STS (0.49) SMN1; SMN2TSHRMAPK1NR1H2ALDH1A1
SCHEMBL2086518 0.77 PARP1 (0.50) CYP2D6KMT2ANR1H2NR1H3ACHE
SCHEMBL30945108 0.77 NR1H2 (0.40) HTR6MEN1KMT2ANR1H2PARP1
SCHEMBL30032878 0.74 MAPT (0.47) SMN1; SMN2MEN1CYP2D6KMT2AHTT
SCHEMBL30911841 0.72 PARP1 (0.40) SMN1; SMN2HSD17B10PARP1
SCHEMBL874416 0.71 NR1H2 (0.49) MAPK1NR1H2NR1H3PARP1
SCHEMBL22285173 0.71 NR1H2 (0.49) MAPK1NR1H2NR1H3PARP1
SCHEMBL4325057 0.71 NR1H2 (0.49) MAPK1NR1H2NR1H3PARP1
SCHEMBL1563776 0.71 STS (0.35) MEN1TSHRKMT2AHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247499-A1 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2009-10-01 — — US disclosed
EP-2056828-A2 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2009-05-13 — — EP disclosed
WO-2008024284-A2 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-02-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247499-A1 SULFONYLATED PIPERAZINES AS CANNABINOID-1 RECEPTOR MODULATORS CNR1, CNR2, FAAH HTR6 432/4885PRKD3 3739/4885PRKCG 2386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback